Evaluation of the recombinant tissue plasminogen activator pretreatment in acute stroke patients with large vessel occlusions treated with the direct bridging approach. Is it worth the effort?

European Journal of Neurology

Volumn 22, Issue 2, 2015, Pages 322-327

  Fjetland, L ^a   Kurz, K D ^a   Roy, S ^a   Kurz, M W ^a  

^a STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Acute ischaemic stroke; Endovascular treatment; Intravenous thrombolysis

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; ARTIFICIAL EMBOLISM; ASPIRATION CATHETER; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CAROTID CAVERNOUS FISTULA; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CONTROLLED STUDY; DIFFUSION WEIGHTED IMAGING; DIGITAL SUBTRACTION ANGIOGRAPHY; DIRECT BRIDGING APPROACH; ENDOVASCULAR SURGERY; FEMALE; FIBRINOLYTIC THERAPY; FUNCTIONAL STATUS; HUMAN; INTERNAL CAROTID ARTERY; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MECHANICAL THROMBECTOMY; MODIFIED THROMBOLYSIS IN CEREBRAL INFARCTION SCALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; RATING SCALE; REPERFUSION; RETROSPECTIVE STUDY; REVASCULARIZATION; STROKE PATIENT; SUBARACHNOID HEMORRHAGE; SURGICAL MORTALITY; THROMBECTOMY DEVICE; TREATMENT RESPONSE; VASCULAR CLOSURE DEVICE; BRAIN CIRCULATION; BRAIN ISCHEMIA; DRUG EFFECTS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROCEDURES; STROKE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; COMBINED MODALITY THERAPY; ENDOVASCULAR PROCEDURES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84920606672     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12569     Document Type: Article

References (28)

1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581-1587.
2. Jauch EC, Saver JL, Adams HP, et al. Guidelines for the early management of patients with acute ischemic stroke. A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2013; 44: 870-947.
3. Saqqur M, Uchino K, Demchuk AM, et al. Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke. Stroke 2007; 38: 948-954.
4. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. JAMA 1999; 282: 2003-2011.
5. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke 2008; 39: 1205-1212.
6. Tarr R, Hsu D, Kulcsar Z, et al. The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe. J Neurointerv Surg 2010; 2: 341-344.
7. Koh JS, Lee SJ, Ryu CW, Kim HS. Safety and efficacy of mechanical thrombectomy with solitaire stent retrieval for acute ischemic stroke: a systematic review. Neurointervention 2012; 7: 1-9.
8. Saver JL, Jahan R, Levy EI, et al. Solitaire flow restoration device versus the MERCI retriever in patients with acute ischemic stroke (SWIFT): a randomized, parallel-group, non-inferiority trial. Lancet 2012; 380: 1241-1249.
9. Nogueira RG, Lutsep HL, Gupta R, et al. Trevo versus Merci retrievers for thrombectomy revascularization of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet 2012; 380: 1231-1240.
10. Fjetland L, Roy S, Kurz KD, Larsen JP, Kurz MW. Endovascular acute stroke treatment performed by vascular interventional radiologists: is it safe and efficacious? Cardiovasc Intervent Radiol 2012; 35: 1029-1035.
11. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med 2013; 368: 893-903.
12. IMS study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the International Management of Stroke study. Stroke 2004; 35: 904-911.
13. IMS II Trial InvestigatorsThe International Management of Stroke (IMS) II study. Stroke 2007; 38: 2127-2135.
14. Flaherty ML, Woo D, Kissela B, et al. Combined IV and intra-arterial thrombolysis for acute ischemic stroke. Neurology 2005; 64: 386-388.
15. Burns TC, Rodriguez GJ, Patel S, et al. Endovascular interventions following intravenous thrombolysis may improve survival and recovery in patients with acute ischemic stroke: a case-control study. AJNR AM J Neuroradiol 2008; 29: 1918-1924
16. Suarez JI, Zaidat OO, Sunshine JL, Tarr R, Selman WR, Landis DMD. Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes. Neurosurgery 2002; 50: 251-260.
17. Tomsick T, Brodrick J, Carrozella J, et al. Revascularization results in the International Management of Stroke II trial. AJNR Am J Neuroradiol 2008; 29: 582-587.
18. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998; 352: 1245-1251.
19. Brott T, Adams HP, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989; 20: 864-870.
20. van Swieten JC, Koudstaal PJ, Visse MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19: 604-607.
21. Bhatia R, Hill MD, Shobha N, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke 2010; 41: 2254-2258.
22. Mazighi M, Serfaty JM, Labreuche J, et al. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol 2009; 8: 802-809.
23. Ribo M, Alvarez-Sabín J, Montaner J, et al. Temporal profile of recanalization after intravenous tissue plasminogen activator: selecting patients for rescue reperfusion techniques. Stroke 2006; 37: 1000-1004.
24. Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999; 30: 2598-2605.
25. Behme D, Gondecki L, Fiethen S, et al. Complications of mechanical thrombectomy for acute ischemic stroke - a retrospective single-center study of 176 consecutive cases. Neuroradiology 2014; 56: 467-476.
26. Mazighi M, Meseguer E, Labreuche J, Amarenco P. Bridging therapy in acute ischemic stroke: a systematic review and meta-analysis. Stroke 2012; 43: 1302-1308.
27. Nogueira RG, Yoo AJ, Masrur S, et al. Safety of full-dose intravenous recombinant tissue plasminogen activator followed by multimodal endovascular therapy for acute ischemic stroke. J Neurointerv Surg 2013; 5: 298-301.
28. Rubiera M, Ribo M, Pagola J, et al. Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients: a case-control study. Stroke 2011; 42: 993-997.